Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Once immortalized, human cells are susceptible to transformation by introduction of an oncogene such as ras . Several lines of evidence now suggest that the maintenance of telomere length is a major determinant of replicative lifespan in human cells and thus of the immortalized state. The majority of human tumor cells acquire immortality through expression of the catalytic subunit of telomerase (hTERT), whereas others activate an alternative mechanism of telomere maintenance (ALT) that does not depend on the actions of telomerase. We have examined whether ALT could substitute for telomerase in the processes of transformation in vitro and tumorigenesis in vivo . Expression of oncogenic H-Ras in the immortal ALT cell line GM847 did not result in their transformation. However, subsequent ectopic expression of hTERT in these cells imparted a tumorigenic phenotype. Indeed, this outcome was also observed after introduction of a mutant hTERT that retained catalytic activity but was incapable of maintaining telomere length. These studies indicate that hTERT confers an additional function that is required for tumorigenesis but does not depend on its ability to maintain telomeres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overexpression experiments in transgenic mice and in human cells have shown that TERT exhibits activities in cellular transformation (136-138), proliferation (139), stem cell biology (140-142), cell survival (143,144) and chromatin regulation (145).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [136]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, recent findings indicate that TERT promotes tumor development even in settings of ample telomere reserve, although the mechanisms underlying these telomere length-independent activities of TERT remain unclear9–13.”
From Conditional telomerase induction causes proliferation of hair follicle stem cells (2005) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Autoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80150-8 · Cited by 149
RetractedAutoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.003 · Cited by 31
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Research works printed but not linked: 4
- Rich J N, Guo C, McLendon R E, Bigner D D, Wang X F, Counter C M. Cancer Res. 2001;61:3556–3560. [PubMed] [Google Scholar]
- Kuperwasser C, Pinkas J, Hurlbut G D, Naber S P, Jerry D J. Cancer Res. 2000;60:2723–2729. [PubMed] [Google Scholar]
- Zimonjic D, Brooks M W, Popescu N, Weinberg R A, Hahn W C. Cancer Res. 2001;61:8838–8844. [PubMed] [Google Scholar]
- Yeager T R, Neumann A A, Englezou A, Huschtscha L I, Noble J R, Reddel R R. Cancer Res. 1999;59:4175–4179. [PubMed] [Google Scholar]
Cited by
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Plaks, V., Kong, N., & Werb, Z. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.015 · Cited by 1,557
“Indeed, p53 inhibition and Human telomerase reverse transcriptase (hTERT) activation (Hahn et al., 1999; Stewart et al., 2002; Hong et al., 2009) or the aberrant acquisition of stemcell-associated factors such as Neurogenic locus notch homolog (NODAL), NOTCH, and Wingless-type MMTV integration site family (WNT) protei…”
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Telomerase modulates Wnt signalling by association with target gene chromatin
Park, J.-I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009) · Nature · doi:10.1038/nature08137 · Cited by 707
(2003) · PubMed · Cited by 608
Homologous Recombination Generates T-Loop-Sized Deletions at Human Telomeres
Wang, R. C., Smogorzewska, A., & de Lange, T. (2004) · Cell · doi:10.1016/j.cell.2004.10.011 · Cited by 512
“…Attrition more, ALT cells have been reported to grow better whenThe most detailed insight in telomere attrition derives telomerase is expressed (Stewart et al., 2002), a resultfrom the work of Kipling and colleagues, who examined expected if telomerase helps to heal telomeres that havethe…”
BackgroundHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
“Recently it has been shown that there is an antiapoptotic function of telomerase, which may be independent of its effect on telomeres (Stewart et al., 2002).”
BackgroundAhmed, S., Passos, J. F., Birket, M. J., Beckmann, T., Brings, S., Peters, H., Birch-Machin, M. A., von Zglinicki, T., & Saretzki, G. (2008) · Journal of Cell Science · doi:10.1242/jcs.019372 · Cited by 491
“A better understanding of the mechanisms involved is of obvious importance, as telomerase is active in the vast majority of human cancers (Shay and Bacchetti, 1997) and might significantly contribute to tumorigenic potential (Bagheri et al., 2006; Stewart et al., 2002) and to the low sensitivity of many cancer cells t…”
BackgroundTERT promoter mutations in thyroid cancer
Liu, R., & Xing, M. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0533 · Cited by 441
“Induced expression of TERT was also shown to promote the development of mammary carcinomas and epidermal tumors in vivo (Gonzalez-Suarez et al. 2001, Stewart et al. 2002).”
BackgroundTelomerase modulates expression of growth-controlling genes and enhances cell proliferation
Smith, L. L., Coller, H. A., & Roberts, J. M. (2003) · Nature Cell Biology · doi:10.1038/ncb985 · Cited by 438
Conditional telomerase induction causes proliferation of hair follicle stem cells
Sarin, K. Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., Wang, E., Artandi, M. K., Oro, A. E., & Artandi, S. E. (2005) · Nature · doi:10.1038/nature03836 · Cited by 425
Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres
O'Sullivan, R. J., Kubicek, S., Schreiber, S. L., & Karlseder, J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1897 · Cited by 416
Telomerase directly regulates NF-κB-dependent transcription
Ghosh, A., Saginc, G., Leow, S. C., Khattar, E., Shin, E. M., Yan, T. D., Wong, M., Zhang, Z., Li, G., Sung, W.-K., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2621 · Cited by 378
Telomeric DNA in ALT Cells Is Characterized by Free Telomeric Circles and Heterogeneous t-Loops
Cesare, A. J., & Griffith, J. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9948-9957.2004 · Cited by 343
“A derivative of the GM847 cell line exogenously expressing the protein subunit of telomerase (GM847-Tert) was also used (39).”
MethodChoi, J., Southworth, L. K., Sarin, K. Y., Venteicher, A. S., Ma, W., Chang, W., Cheung, P., Jun, S., Artandi, M. K., Shah, N., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.0040010 · Cited by 336
“These results are consistent with the findings of others showing that TERT acts in transformation and the DNA damage response independent of its ability to lengthen telomeres [66,67].”
ResultTelomeres: Cancer to Human Aging
Stewart, S. A., & Weinberg, R. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104518 · Cited by 334
“Another study has demonstrated that ectopic expression of wild-type hTERT allows nontumorigenic ALT cells (cells that possess long telomeres but do not express endogenous hTERT) to form tumors (Stewart et al. 2002).”
BackgroundSelf-citationLiu, Z., Li, Q., Li, K., Chen, L., Li, W., Hou, M., Liu, T., Yang, J., Lindvall, C., Björkholm, M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.441 · Cited by 276
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
Hakin-Smith, V, Jellinek, D., Levy, D., Carroll, T., Teo, M., Timperley, W., McKay, M., Reddel, R., & Royds, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12681-5 · Cited by 267
Regulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 266
“…normal cells, such as epithelial cells and human fibroblasts (Artandi et al., 2002; Gonzalez-Suarez et al., 2002; Gonzalez-Suarez et al., 2001; Stewart et al., 2002; Qi et al., 2011), and the ectopic expression of hTERT along with activated oncogenes results in tumorigenesis (Hahn et al.,…”
BackgroundMitochondrial hTERT exacerbates free‐radical‐mediated mtDNA damage
Santos, J. H., Meyer, J. N., Skorvaga, M., Annab, L. A., & Van Houten, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00124.x · Cited by 264
Telomerase: central regulator of all of the hallmarks of cancer
Low, K. C., & Tergaonkar, V. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.07.001 · Cited by 257
Kelland, L. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.11.024 · Cited by 252
Liu, T., Wang, N., Cao, J., Sofiadis, A., Dinets, A., Zedenius, J., Larsson, C., & Xu, D. (2014) · Oncogene · doi:10.1038/onc.2013.446 · Cited by 251
Telomere dysfunction as a cause of genomic instability in Werner syndrome
Crabbe, L., Jauch, A., Naeger, C. M., Holtgreve-Grez, H., & Karlseder, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609410104 · Cited by 240
TERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238
Actions of human telomerase beyond telomeres
Cong, Y., & Shay, J. W. (2008) · Cell Research · doi:10.1038/cr.2008.74 · Cited by 229
Santos, J. H., Meyer, J. N., & Van Houten, B. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl098 · Cited by 208
“For these experiments, we used GM847 cells that do not express hTERT endogenously and that maintain long telomeres through a telomerase-independent pathway (17).”
MethodMoore, M. J. B., Schultes, C. M., Cuesta, J., Cuenca, F., Gunaratnam, M., Tanious, F. A., Wilson, W. D., & Neidle, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050555a · Cited by 206
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & Lleonart, M. (2016) · BioEssays · doi:10.1002/bies.201670911 · Cited by 199
The role of telomeres in skin aging/photoaging
Kosmadaki, M. G., & Gilchrest, B. A. (2004) · Micron · doi:10.1016/j.micron.2003.11.002 · Cited by 199
Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis
Singhapol, C., Pal, D., Czapiewski, R., Porika, M., Nelson, G., & Saretzki, G. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052989 · Cited by 196
“In addition, telomerase contributes to tumorigenesis via nontelomere dependent mechanisms which are not well understood yet [16].”
The role of stem cells in aging
Van Zant, G., & Liang, Y. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00088-2 · Cited by 195
“Telomerase, a heterodimer consisting of a protein catalytic subunit which acts as a reverse transcriptase, and an RNA subunit responsible for hybridizing with DNA telomere repeats, is now recognized to have a complex role in telomere biology [145,152–155].”
BackgroundAlternative lengthening of telomeres, telomerase, and cancer
Reddel, R. R. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00702-4 · Cited by 191
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations
Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., & Khavari, P. A. (2005) · Nature Genetics · doi:10.1038/ng1586 · Cited by 198
“Cessation of mitotic activity in the absence of hTERT coexpression did not accompany this finding, consistent with its reported effects on tumorigenesis beyond promoting immortalizatio”
ResultBechter, O. E., Zou, Y., Walker, W., Wright, W. E., & Shay, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0323 · Cited by 184
“It has been shown previously that the ALT pathway does not substitute for telomerase in the process of tumorigenesis in vivo (15).”
BackgroundInfluentialHuman telomerase acts as a hTR-independent reverse transcriptase in mitochondria
Sharma, N. K., Reyes, A., Green, P., Caron, M. J., Bonini, M. G., Gordon, D. M., Holt, I. J., & Santos, J. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr758 · Cited by 179
“GM847 cells are immortalized through a telomeraseindependent pathway and therefore do not have detectable levels of endogenous hTERT (23).”
BackgroundUlaner, G. A., Huang, H.-Y., Otero, J. E., Zhao, Z., Ben‐Porat, L., Satagopan, J. M., Gorlick, R. G., Meyers, P. A., Healey, J. H., Huvos, A. G., et al. (2003) · PubMed · Cited by 210
Chang, S., Khoo, C. M., Naylor, M. L., Maser, R. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1029903 · Cited by 183
“In addition, recent evidence suggests that telomerase has additional roles beyond those involved in telomere maintenance (Stewart et al. 2002; for review, see Chang and DePinho 2002).”
BackgroundDe Vitis, M., Berardinelli, F., & Sgura, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020606 · Cited by 182
“On the other hand, stem cells, germ line cells and the majority of tumors show telomerase activity [12,13].”
BackgroundRegulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
Liu, R., Zhang, T., Zhu, G., & Xing, M. (2018) · Nature Communications · doi:10.1038/s41467-018-03033-1 · Cited by 178
Noncanonical Functions of Telomerase: Implications in Telomerase-Targeted Cancer Therapies
Li, Y., & Tergaonkar, V. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3568 · Cited by 172
Burns, J. S., Abdallah, B. M., Guldberg, P., Rygaard, J., Schrøder, H. D., & Kassem, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2218 · Cited by 161
“(14, 15) is consistent with evidence that it enhances cell proliferation (16).”
BackgroundExtra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Saretzki, G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630095606 · Cited by 156
“demonstrated a pro-tumourigenic function for hTERT independent of hTR [38].”
BackgroundThe Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Li, S., Crothers, J., Haqq, C. M., & Blackburn, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502782200 · Cited by 158
Telomere maintenance and cancer ? look, no telomerase
Neumann, A. A., & Reddel, R. R. (2002) · Nature reviews. Cancer · doi:10.1038/nrc929 · Cited by 191
“One ALT cell line was more likely to become tumorigenic if transduced with expression constructs for both activated RAS and TERT than if transduced with RAS alon”
BackgroundhTERT antagonizes p53-induced apoptosis independently of telomerase activity
Rahman, R., Latonen, L., & Wiman, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208232 · Cited by 158
“…Cancer Center Karolinska (CCK), R8:04, Karolinska Institute, SE-171 76 Stockholm, Sweden; E-mail: Klas.Wiman@cck.ki.se Oncogene (2005) 24, 1320–1327 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc its ability to maintain telomeres (Stewart et al., 2002).”
BackgroundResultInfluentialKaboli, P. J., Rahmat, A. B., Ismail, P., & Ling, K. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.025 · Cited by 157
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway
Massard, C., Zermati, Y., Pauleau, A.-L., Larochette, N., Métivier, D., Sabatier, L., Kroemer, G., & Soria, J.-C. (2006) · Oncogene · doi:10.1038/sj.onc.1209487 · Cited by 144
“It has been suspected for long that hTERT may contribute to tumorigenesis by a telomere lengthindependent mechanism because mutant hTERT, incapable of maintaining telomere length, can transform cell lines in vitro (Stewart et al., 2002).”
BackgroundMechanisms leading to chromosomal instability
Gollin, S. M. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.09.004 · Cited by 164
Costa, A., Daidone, M. G., Daprai, L., Villa, R., Cantù, S., Pilotti, S., Mariani, L., Gronchi, A., Henson, J. D., Reddel, R. R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0273 · Cited by 140
Coevolution of telomerase activity and body mass in mammals: From mice to beavers
Gorbunova, V. A., & Seluanov, A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.008 · Cited by 148
“Telomerase was shown to promote cell growth, transformation, and protects cells from apoptosis (Chang and DePinho, 2002; Gorbunova et al., 2002; Stewart et al., 2002; Gorbunova and Seluanov, 2003).”
BackgroundAlterations in the Smad pathway in human cancers
Samanta, D., & Datta, P. K. (2011) · Frontiers in bioscience · doi:10.2741/3986 · Cited by 143
“Expression of hTERT stimulates cell proliferation toward immortality (60-64) and contributes to tumor formation (65, 66).”
BackgroundRole of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 143
Self-citationMunro, J., Barr, N. I., Ireland, H., Morrison, V., & Parkinson, E. K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.017 · Cited by 141
Yang, C., Przyborski, S., Cooke, M. J., Zhang, X., Stewart, R., Anyfantis, G., Atkinson, S. P., Saretzki, G., Armstrong, L., & Lako, M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0677 · Cited by 136
A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis
Trapp, S., Parcells, M. S., Kamil, J. P., Schumacher, D., Tischer, B. K., Kumar, P. M., Nair, V., & Osterrieder, N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052240 · Cited by 141
Hrdličková, R., Nehyba, J., & Bose, H. R. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00550-12 · Cited by 123
Fu, L., Chen, W., Guo, W., Wang, J., Tian, Y., Shi, D., Zhang, X. M., Qiu, H., Xiao, X., Kang, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069240 · Cited by 137
Mechanisms of chromosome instability in cancers
Jefford, C. E., & Irminger‐Finger, I. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.005 · Cited by 159
Problems of somatic mutation and cancer
Frank, S. A., & Nowak, M. A. (2004) · BioEssays · doi:10.1002/bies.20000 · Cited by 123
“High telomerase expression may also have other cancer-stimulating effects.((56,57)) If possible, it would be interesting to study the consequences for cellular fitness of later-stage reduced chromosomal instability independently of other effects on cancer progression.”
BackgroundGenes and pathways downstream of telomerase in melanoma metastasis
Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., LaPosa, R. R., Baehner, F. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510085103 · Cited by 129
Telomerase, mitochondria and oxidative stress
Saretzki, G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.05.004 · Cited by 128
Wu, Y.-L., Dudognon, C., Nguyen, E., Hillion, J., Pendino, F., Tarkanyi, I., Aradi, J., Lanotte, M., Tong, J.-H., Chen, G.-Q., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.03001 · Cited by 126
Wang, L. L. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00005 · Cited by 129
Evolving views of telomerase and cancer
Blasco, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00085-0 · Cited by 123
New prospects for targeting telomerase beyond the telomere
Arndt, G. M., & MacKenzie, K. L. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.55 · Cited by 132
On the road to immortality: hTERT upregulation in cancer cells
Janknecht, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00356-4 · Cited by 116
Engineered telomere degradation models dyskeratosis congenita
Hockemeyer, D., Palm, W., Wang, R. C., Couto, S. S., & de Lange, T. (2008) · Genes & Development · doi:10.1101/gad.1679208 · Cited by 116
“Mouse telomeres recapitulate most aspects of human telomere biology, although differences in telomerase regulation, the telomere damage response pathway, and the composition of shelterin have been noted (Prowse and Greider 1995; Smogorzewska and de Lange 2002; Jacobs and de Lange 2004; Hockemeyer et al. 2006, 2007).”
BackgroundMarek’s disease virus: lytic replication, oncogenesis and control
Jarosinski, K. W., Tischer, B. K., Trapp, S., & Osterrieder, N. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.761 · Cited by 116
Lu, J.-J., Fu, L., Tang, Z., Zhang, C., Qin, L., Wang, J., Yu, Z., Shi, D., Xiao, X., Xie, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6407 · Cited by 114
“hTERT is an important component of human telomerase, which lengthens chromosome ends and maintains chromosomal stability, leading to cellular immortalization [53].”
BackgroundTelomere and Telomerase Therapeutics in Cancer
Xu, Y., & Goldkorn, A. (2016) · Genes · doi:10.3390/genes7060022 · Cited by 122
“Expression of telomerase protein (TERT) in fibroblasts which had been immortalized with SV40 and H-Ras rendered the cells highly tumorigenic, an effect equally conferred by TERT-HA, a variant that was incapable of elongating telomeres in vivo [51].”
BackgroundLiu, N., Ding, D., Hao, W., Yang, F., Wu, X., Wang, M., Xu, X., Ju, Z., Liu, J., Song, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw549 · Cited by 115
Telomerase Expression Predicts Unfavorable Outcome in Osteosarcoma
Sanders, R. P., Drissi, R., Billups, C. A., Daw, N. C., Valentine, M. B., & Dome, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.043 · Cited by 122
Kovalenko, O. A., Caron, M. J., Ulema, P., Medrano, C., Thomas, A. P., Kimura, M., Bonini, M. G., Herbig, U., & Santos, J. H. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00551.x · Cited by 108
“GM847 are immortalized cell lines that maintain telomeres through the ALT (alternative lengthening of telomeres) pathway (Stewart et al., 2002).”
BackgroundMethodCHUNG, S. S., Aroh, C., & Vadgama, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083971 · Cited by 117
Non-canonical Roles of Telomerase: Unraveling the Imbroglio
Ségal-Bendirdjian, E., & Géli, V. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00332 · Cited by 113
Separation of telomerase functions by reverse genetics
Mukherjee, S., Firpo, E. J., Wang, Y., & Roberts, J. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112414108 · Cited by 100
“Ectopic telomerase expression can also confer resistance to antiproliferative and proapoptotic stimuli (18–21) and enhance proliferation of diverse cell types such as mouse embryonic fibroblasts (18), cardiac myocytes (22), and human fibroblasts (23).”
BackgroundMethodResultInfluentialNormal Human Fibroblasts Are Resistant to RAS-Induced Senescence
Benanti, J. A., & Galloway, D. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2842-2852.2004 · Cited by 103
“In addition, human fibroblasts that are immortalized by a telomerase-independent mechanism are not transformed by RAS unless hTert is also expressed (43).”
BackgroundComparison of early passage, senescent and hTERT immortalized endothelial cells
Chang, M. W.-F., Grillari, J., Mayrhofer, C., Fortschegger, K., Allmaier, G. M., Marzban, G., Katinger, H. W. D., & Voglauer, R. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.002 · Cited by 111
Rehe, K., Wilson, K., Bomken, S. N., Williamson, D., Irving, J. A. E., den Boer, M. L., Stanulla, M., Schrappe, M., Hall, A. G., Heidenreich, O. T., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201703 · Cited by 113
“TERT protein supports the maintenance and expansion of normal and cancer stem cells both by telomerase-dependent and -independent mechanisms (Stewart et al, 2002).”
Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria
Chiodi, I., & Mondello, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00133 · Cited by 97
“However, the study of genetically modified cells or mice in which TERT had been exogenously expressed also revealed novel telomerase functions in tumorigenesis (GonzalezSuarez et al., 2001; Artandi et al., 2002; Stewart et al., 2002; Canela et al., 2004).”
BackgroundLindvall, C. J., Hou, M., Komurasaki, T., Zheng, C., Arsenian‐Henriksson, M., Sedivy, J. M., Björkholm, M., Teh, B. T., Nordenskjöld, M., & Xu, D. (2003) · PubMed · Cited by 106
Telomeres and telomerase as targets for anticancer drug development
Olaussen, K. A., Dubrana, K., Dômont, J., Spano, J., Sabatier, L., & Soria, J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.007 · Cited by 111
Chapman, E., Hurst, C. D., Pitt, E., Chambers, P. A., Aveyard, J. S., & Knowles, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209513 · Cited by 99
“This apparent contradiction between the necessity of p16 loss for in vitro immortalisation of (telomerase positive) UCC but not NHUC may be explained in light of recent insight into the telomereindependent actions of hTERT expression (Stewart et al., 2002; Smith et al., 2003).”
BackgroundTelomerase: regulation, function and transformation
Dong, C. K., Masutomi, K., & Hahn, W. C. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.12.005 · Cited by 106
Self-citationTERT biology and function in cancer: beyond immortalisation
Pestana, A., Vinagre, J., Sobrinho-Simões, M. A., & Soares, P. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0195 · Cited by 113
Age-associated telomere attrition in adipocyte progenitors predisposes to metabolic disease
Gao, Z., Daquinag, A. C., Fussell, C., Zhao, Z., Dai, Y., Rivera, A., Snyder, B. E., Eckel-Mahan, K. L., & Kolonin, M. G. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00320-4 · Cited by 92
Nakamura, M., Masutomi, K., Kyo, S., Hashimoto, M., Maida, Y., Kanaya, T., Tanaka, M., Hahn, W. C., & Inoue, M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.859 · Cited by 97
Self-citationCanela, A., Martín-Caballero, J., Flores, J. M., & Blasco, M. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4275-4293.2004 · Cited by 90
“In addition, evidence obtained using cultured cells also supports a role of telomerase in promoting growth and survival independent of its role in net telomere elongation (28, 29).”
BackgroundLee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 86
“(50) have shown functional dissection of telomerase and the telomerase enzymatic activity, specifically that telomere elongation activity was not critical for tumorigenesis.”
BackgroundThe telomere length dynamic and methods of its assessment
Lin, K.-W., & Yan, J. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00395.x · Cited by 85
“The telomerase functions as a reverse transcriptase in the elongation of telomere length, in which the TERC act as a template for telomere synthesis, and TERT catalyze the elongation [13, 14].”
BackgroundDudognon, C., Pendino, F., Hillion, J., Saumet, A., Lanotte, M., & Ségal-Bendirdjian, E. (2004) · Oncogene · doi:10.1038/sj.onc.1208029 · Cited by 98
“Recent findings indicate that telomerase confers additional function required for tumorigenesis that does not depend on its ability to maintain telomeres (Stewart et al., 2002).”
BackgroundCudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness
Choi, M., Cho, K. H., Lee, S., Bae, Y. J., Jeong, K., Rha, S. Y., Choi, E. J., Park, J. H., Kim, J., Lee, J. S., et al. (2014) · Oncogene · doi:10.1038/onc.2014.270 · Cited by 86
FEN1 Ensures Telomere Stability by Facilitating Replication Fork Re-initiation
Saharia, A., Teasley, D. C., Duxin, J. P., Dao, B., Chiappinelli, K. B., & Stewart, S. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112276 · Cited by 96
Self-citationTerrin, L., Col, J. D., Rampazzo, E., Zancai, P., Pedrotti, M., Ammirabile, G., Bergamin, S., Rizzo, S., Dolcetti, R., & Rossi, A. D. (2008) · Journal of Virology · doi:10.1128/jvi.00321-08 · Cited by 88
“Furthermore, several pieces of data suggest that besides the maintenance of telomere length, hTERT is also involved in other cellular functions, including promotion of cell growth (6, 49) and survival (10, 39, 45), thus contributing to tumorigenesis by mechanisms independent of its ability to prevent telomere erosion…”
BackgroundTelomere Maintenance Mechanisms in Cancer: Clinical Implications
Reddel, R. R. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630101047 · Cited by 97
“However, in vitro studies in which exogenous telomerase was expressed in ALT cells have demonstrated that both TMMs can co-exist within an individual cell [203-207].”
BackgroundQuantitative assessment of telomerase components in cancer cell lines
Akıncılar, S. C., Low, K. C., Liu, C. Y., Yan, T. D., Oji, A., Ikawa, M., Li, S., & Tergaonkar, V. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.035 · Cited by 79
“This telomere independent ability of hTERT could explain why expression of hTERT, even in its catalytically inactive form, confers properties to cells that resemble those of the hallmarks of cancers [22–24].”
BackgroundGlutathione S-Transferase π1 Promotes Tumorigenicity in HCT116 Human Colon Cancer Cells
Dang, D. T., Chen, F., Kohli, M., Rago, C., Cummins, J. M., & Dang, L. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1930 · Cited by 80
“supplemented with 10% or 1% FBS and 1% penicillin/streptomycin (28, 29 ).”
Metadata
- Authors
- Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., Popescu, N. C., & Weinberg, R. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Adult Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA 02115; Genzyme, Inc., One Kendall Square, Cambridge, MA 02139; Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD 20892; and Department of Biology, Massachusetts Institute of...
- Corresponding author
- Weinberg, Robert A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-22
- Volume
- 99
- Issue
- 20
- Pages
- 12606-12611
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC130507
- OpenAlex
- W2154837214
- Cited by
- 431
- References
- 53
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 5 · 2017: 14 · 2016: 21 · 2015: 18 · 2014: 22 · 2013: 15 · 2012: 18
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- American Association for Cancer Research
- W. M. Keck Foundation
- Ludwig Institute for Cancer Research
- National Institutes of Health
- National Cancer Institute (KO1CA94223, R01 CA78461, K01CA094223, R01CA078461)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, hTERT, alternative lengthening of telomeres, carcinogenesis, cell transformation, cell immortalization, replicative lifespan
- MeSH terms
- Catalysis, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Glucose, Humans, Karyotyping, Kinetics, Luminescent Proteins, Microscopy, Fluorescence, Oxygen, Retroviridae, Time Factors, Tumor Cells, Cultured, Blotting, Western, Telomere, Telomerase, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.